
Lexicon Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Lexicon Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lexicon Pharmaceuticals Inc
Access all reports
Lexicon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of diseases with significant unmet medical needs. The company leverages its expertise in gene science to discover and develop small-molecule drugs aimed at addressing serious conditions such as heart disease, diabetes, and cancer. Lexicon's drug development approach involves targeting specific molecular pathways to create novel therapies that can alter the course of these diseases and improve patient outcomes. The company is headquartered in The Woodlands, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
LXRX
Country
🇺🇸 United States